chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I went through a mini covid again, when I first started I had chills for like 7 hours, I had chills so bad I came from work and after that I was hot. I had all the symptoms I had with covid it lasted 3-4 days. I had a fever, i couldn't get out of bed I lost my taste and smell. On Monday , I was perfect.
Vaccine administered to patient below approval age; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to patient below approval age) in a 17-month-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Nov-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to patient below approval age). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to patient below approval age) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported. Patient received one dose of the moderna COVID-19 vaccine as part of a research trial on 29 Nov 2021.
Pt recvd vax on 11MAY92 & on 28MAY92 pt exp numbness of rt arm, shoulder, face & neck w/tingling that radiated down fingers;
Adhesive capsulitis, pain, range of motion, recent MRI 2 tears with cyst.
Severe chest pain sometimes less but pain never goes away. shortness of breath, cough when lying down, thick sticky phlegm, sometimes body pain, very tired, headache, sometimes cloudy vision.
pt recvd vax 4OCT95 & believed the inj was given too high; exp immediate arm pain which cont to persist; pt encouraged to consult MD
lost of appetite,; fever,; cough; swollen leg on where the patient received KINRIX; one patient received improperly stored PROQUAD; This spontaneous report was received from a physician and refers to a 14-month-old female patient. The patient's concomitant medications, pertinent medical history, concurrent conditions, drug reactions or allergies were not reported.  On 13-JUL-2022, the patient was vaccinated with improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) subcutaneous injection, 1 dose, lot #W010525, expiration date: 25-SEP-2023 (exact dose, vaccination schedule and route of administration were not provided) administered on a leg (unspecified) for prophylaxis (product storage error).  On the same day, the patient was vaccinated with diphtheria vaccine toxoid, pertussis vaccine acellular 3-component, polio vaccine inact 3v (vero), tetanus vaccine toxoid (KINRIX) (formulation, dose, lot #, expiry date, and route of administration were not provided) administered on the opposite leg for prophylaxis.  On 13-JUL-2022, the patient experienced loss of appetite, fever, cough, and developed swollen leg on where the patient received diphtheria vaccine toxoid, pertussis vaccine acellular 3-component, polio vaccine inact 3v (vero), tetanus vaccine toxoid (KINRIX).  At the time of reporting, the outcome of the events: loss of appetite, fever, cough, and swollen leg was unknown.   The causal relationship between the events loss of appetite, fever, cough, swollen leg, and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was not provided.
Tiredness at the second day of vaccination (12/23/2020) and swollen tender left axillary lymph node started (12/26/2020) and still ongoing till the date of filing the adverse event (12/28/2020).
This spontaneous report was received from a physician refers to a patient of unknown age(gender unspecified). On 13-JUL-2011, the patient was vaccinated with first dose of RECOMBIVAX HB, (lot number, expiry date was not reported and route intramuscular). On 16-AUG-2011, the patient was vaccinated with second dose of RECOMBIVAX HB, (lot number, expiry date was not reported and route was intramuscular). On 01-FEB-2013, the patient was vaccinated with third dose of RECOMBIVAX HB, (lot number, expiry date was not reported and route was intramuscular). Concomitant medications were not reported. The reporter stated that the patient received the third dose late. The first two doses were age appropriate, pediatric formulation RECOMBIVAX HB and the third dose was age appropriate adult formulation RECOMBIVAX HB. No adverse effect reported. Additional information has been requested.
received expired dose; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 68-year-old male patient who received Herpes zoster (Shingrix) (batch number XG52X, expiry date 28th November 2021) for prophylaxis.   On 21st January 2022, the patient received the 2nd dose of Shingrix. On 21st January 2022, unknown after receiving Shingrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.  Additional details were reported as follows: The patient received second dose of Shingrix on 21st January 2022 which was expired on 28th November 2021, which led to expired dose administration. Consent to follow up was granted.
I felt severe shivering between 2 a.m. and 6 a.m. on Jan. 14. After the shivering was gone, then mild or severe headache has been continued until now.
She reported that the side effects started around noon on the day that she received the vaccine (her appointment was at 10 AM on Tuesday April 6th). Patient reported lots of stomach and trunk pain (she was unable to walk straight up and had to leave work early) but she did not report any nausea, vomiting, diarrhea or constipation. Patient reported a fever at a maximum 103.6F at 2:30 PM Wednesday April 7th but it ranged from 99.9F to 101F otherwise. She reported taking Tylenol throughout the day and hydrating but she said that she didn't eat Tuesday into Wednesday because she lost her appetite and was in pain. She said the trunk pain was causing her difficulty in breathing. By 7:00 PM Wednesday, all of her symptoms were resolved and she felt fine.
This spontaneous report was received from a Registered Nurse (R.N.) concerning a patient of unknown age and gender. No concurrent conditions or medical history were reported. On 12-MAY-2014, the patient was vaccinated with the first dose of GARDASIL 0.5 ml/once intramuscular (Lot No. was not reported). Then, on 20-MAY-2015, the patient received the second dose of GARDASIL 9 (Lot No. K026246 Expiration date: 28-JAN-2017), 0.5 ml/once intramuscular. No adverse effect was reported. Additional information has been requested.
pt recv vax 24NOV97 & 2 days post vax an unspecified HIV test was positive;however, a western blot was negative;the reporter indicated that this pt prior HIV test in 1995 was negative;
fever on day 4-8;diarrhea, w vesicular lesions on nose on day 4-6;tx APAP, simple diet;
The client was mistakenly vaccinated prior to the due date for his second Moderna dose.  The second dose was given only 18 days after the first dose.
12MAR91 admitted to Hosp post vax w/febrile seizure; admitted to Ped ICU p/being intubated in ER;  mom noted stiffness & jerking; emergency personnel noted tonic clonic sz activity & was unresponsive; cyanotic, t100.7; Dx OM, anemia, feb sz
this was my second varicella vaccine in 2 weeks. no reaction to the first one at all.  2:30 shot was not abnormally painful upon administration 2:45 numbness tingling and weakness at injection site (L deltiod) 3:00 numbness tingling and weakness has traveled down my left arm to my fingertips. my arm feels like it weighs 100 pounds and it is hard to lift 3:30 stiffness, numbness and tingling travels up my neck 4:00 symptoms now on the left side of my face tongue and throat 4:20 NP (the shot administrator) tells me to go to the ER 4:25 weakness in my left leg, difficulty walking to the car and into the ER 4:30 ish arrive at ER get into a bed they triage me in the bed and i realize i can no longer move my left arm or leg. the symptoms are now beginning in my right arm. they pushed 50mg iv Benadryl then iv drip of solumedrol followed by a saline drip 730 i am not sure of the times i was woken up throughout the three hours i was in and out of sleep. each time my mom woke me up i seemed to regain a little more movement after the drug treatment. by 730 i had full movement back! my arm still is painful and a little weak at the injection site. my leg was still weak but seemed to be fully functional. 7/19/2011 - i feel good still have pain and mild weakness in my left deltoid. on prednisone and otc Benadryl as needed. have been advised to follow up with my regualr doctor this week. will be doing that as well as going to my allergist to see if i can have scratch tests to figure out what in the shot caused my reaction.
9/25 4:30 mom brought child in for assessment of his upper arm.  Redness in 2 inches in diameter with fine red raised rash, warm to the touch.  Mom stated he complained of itching.  She just noticed  it 9/24 around 8 pm.  She stated gave him motrin it looked better not as swollen as it was.  advised parent ot give benedryl and use cortaid creme on site for itching.  If swelling continues any drainage, or increased pain take child to er.
02/19/23 presents to ED for "fever, chills, myalgias, headache". PMHx of "Lambert Eaton syndrome on rituximab and prednisone, asthma"
delayed cutaneous hypersensitivity firmness and redness at the site where the injection occurred ,  itching, and say the lesion is painful/hot to touch,
Headache; Bodyache; This is a spontaneous report from a contactable consumer. A 35-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20Apr2021 at 16:45 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Other medical history not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vitamin d nos (VITAMIN D) from an unknown date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 30Mar2021 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021, the patient experienced headache and body ache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache and body ache was unknown at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
COVID-19 Breakthrough Case. 8/20/21: Patient arrived at the ER SNF due to 4 days of SOB and dry cough as well as non radiating central chest tightness. Tested positive for covid-19 on 8/20/21.  Diagnosed and treated for covid-19 pneunonia and respiratory failure. 8/24/21: Patient discharged back to SNF Please note: Patient received first dose Pfizer vaccine on 2/26/2021 Lot # EL9265 and the second dose on 3/19/2021 Lot # EP7534.
Information has been received from an RN concerning a 68 year old white female with no past medical hx who on 17OCT2003 at 10:00 AM was vaccinated with a second dose of pneumococcal vaccine 23v polysaccharide vaccine, IM in the right deltoid. There was no concomitant medication or illness at the time of vaccination. On 18OCT2003 at 12:30 PM , the pt developed a "hot, swollen, red arm where dose of pneumococcal vaccine 23v polysaccharide vaccine  shot was given. It was also reported that the pt developed a painful arm. The pt recovered on 20OCT2003. There were no relevant diagnostic tests or laboratory data. It was also noted that the pt had received the first dose of pneumococcal 23v polysaccharide vaccine in 1998. It was also reported that four other pts had a similar reaction. Additional information is not expected.
p/vax pt devel redness, warmth whole upper arm, severe diaphoresis & pre-syncope;to ER & hosp overnoc; 60 day follow-up states the pt has recovered.
Patient felt nauseous after vaccine.  Patient ate a piece of fruit while seated and symptoms resolved.
Patient developed temperature of 102.2 within 8 hours if immunization temp 102-103 for 12 hours. Pt given Tylenol every 6 - decreased temp to 99.4. Pt had some response with 1st dose of PREVNAR - also had underlying ear infection. Low - grade fever.
Positive Covid test after vaccination. Woke up congested and sore throat in middle of the night. Headache and body ache continues with congestion.
Information has been received from a physician concerning a patient who "about one month ago" was vaccinated with a dose of RECOMBIVAX HB. Subsequently the patient developed generalized itching and rash 2 hours after administration of vaccine. Medical attention was sought. There was no respiratory distress. The symptoms resolved spontaneously 2 hours later without treatment. The patient was fully recovered. No product complaint was involved. Follow up information from the physician's office staff reported that the physician does not have any information of the patient involved. Further information is not expected.
Fever up to 102.2F Headache Sleepy Muscle and body aches Sore injection site
severed headache; chills; fever of 102; This is a spontaneous report received from a contactable Nurse (patient herself). A 56-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EL9261), via an unspecified route of administration, administered in Arm Left on 28Jan2021 08:15 (at the age of 56-year-old) as 1st dose, single for COVID-19 immunization. Medical history included drug hypersensitivity (penicillin) from an unknown date and unknown if ongoing, patient had no other medical history. Concomitant medication(s) included calcium, vitamin d nos and paracetamol (TYLENOL) taken for an unspecified indication, start and stop date were not reported. Patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. On 02Feb2021 15:00 the patient experienced severe headache, chills and fever of 102. Patient was not diagnosed with COVID-19 Prior to vaccination. The patient underwent lab tests and procedures which included body temperature: 102 on 02Feb2021 Fever, polymerase chain reaction: negative on 04Feb2021, sars-cov-2 test: negative on 04Feb2021. The reporter assessed all the events as non-serious. The outcome of the events was reported as recovering.  Follow-up attempts are completed. No further information is expected.
Vaccine was expired as of 5/30/2023. Patient did not report any adverse symptoms.
administered ipol vaccine instead of pneumococcal vaccine with no reported adverse event; Initial information was received on 03-Aug-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case is linked to case 2023SA239268.  This case involves an unknown age and unknown gender patient who was administered IPV (VERO) [IPOL] instead of pneumococcal vaccine with no reported adverse event   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a 0.5 ml dose of suspect IPV (VERO) Suspension for injection, unknown dose of suspect pneumococcal vaccine produced by unknown manufacturer (unknown formulation) (lot number, expiry date, strength, was unknown) via unknown route in unknown administration site for prophylactic vaccination  (Immunization). The information on the batch number was requested.  On an unknown date the patient was administered ipol vaccine instead of pneumococcal vaccine with no reported adverse event (wrong product administered) (latency: same day) following the administration of IPV (VERO) and (unknown latency) following the administration of pneumococcal vaccine.  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Starting about 36 hours after injections, severe headache and nausea lasting about 24 hours. No fever or vomiting. It is possible that this was due to other stress and unrelated to shots, but felt it should be reported. Symptoms gone at 72 hours after shots.
pt was noted pale ad diaphoretic and sudden loss of consciousness. Placed on flat surface and legs elevated. Regained consciousness after 10 seconds. Vital signs initiated, cold pack provided,  offer water. No other complains presented. Closely monitored for 30 mins.  Symptoms resolved left at 12:20 in stable conditions. Health education provided.
irregular periods for 9 months after injection. I have been on birth control for over a decade and have had 3-4 periods every 27-29 days (during my placebo week) since my first year of starting birth control . After receiving my vaccination, I had a one-day period while still on the hormone pill. I got two periods the following month and continued to have double months and skipped months for the last 9 months. My period is just now starting to become regular again. This has never happened with any other vaccine or medication I have ever taken.
arm/shoulder pain, tenderness, swelling at injection site. Arm feels heavy, numbness and tingling into hand.
Experienced extreme fatigue and muscle weakness during military physical fitness exam. Attempted several treatments until diagnosis in December 2008.
body aches; really bad headache; her head feels prickly on her forehead; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious), outcome "unknown", described as "body aches"; HEADACHE (non-serious), outcome "unknown", described as "really bad headache"; PARAESTHESIA (non-serious), outcome "unknown", described as "her head feels prickly on her forehead".  Additional Information: The patient wanted to know if the side effects were normal. The patient also has questions in regard to the Covid vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This is a spontaneous report received from contactable reporter(s) (Consumer or other non-healthcare professional). The reporter is the patient. A 60-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 17Jun2022 as dose 4 (booster), single (Batch/Lot number: Unknown) at the age of 60 years, in left arm for covid-19 immunisation, coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: Unknown), as dose 2, single (Batch/Lot number: Unknown) and as dose 3 (booster), single (Batch/Lot number: Unknown) for covid-19 immunisation. The patient relevant medical history included: "Psoriasis" (unspecified if ongoing). The patient concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical Information: Other medication in 2 weeks was Unknown. It was reported patient received Covid treatment. Treatment start date: 02Aug2022, Treatment stop date- 05Aug2022. Adverse event was Runny nose, congestion. No known allergies. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient had L arm bulla and black eschar at the injection site, followed by chronic fatigue and diarrhea.
Patient described intractable vomiting, dehydration, blood sugar over 800.  Patient went to hospital and was admitted to ICU for approximately 4 days.  Patient has been discharged from the hospital.
Within 2 days of injection client passed out at school and again at hiome, no other s/s of illness. Admitted to hosp. for tests, all neg. Has passed out 9 times since 1st injection. Has had headachs almost daily since inj. Has been unconsious up to 5 min. and transported to hosp. by ambulance x2, wakes up with C/O Headache and blurred vison. Mom denies history of siezures, has seen pediatric cardiologist, just completed tilt table test, no results as of yet. Has been hospitalized 2 days after 1st episode and 4 days at a later time. Client has had 2nd HPV 08/07/2007 along with Hep A, Var,and MCV4, has continued with faint, but not increase in incidence since 2nd HPV  4/15/2009 Received Cardio consult of 2/3-3/2/2009. FINAL DX: none provided Records reveal patient seen for dizziness, presyncope & syncopal episodes of the past year w/increased frequency over past few wks.  Episodes preceded by dizziness, blurred vision, feeling of weakness & warmth followed by brief LOC & prompt recovery.  Had been hospitalized end of Jan 09.  RTC 3/2 for (+) tilt-table test & tx w/meds & fluid increase.
sore and red; sore and red; arm pain at injection site; This is a spontaneous report from a contactable consumer (patient). A 73-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: EL9266), via an unspecified route of administration, administrated in left arm, on 12Feb2021 about 2pm (age at the time of vaccination 73-years-old) as a single dose for COVID-19 immunization. The patient previously received first dose of BNT162b2 vaccine, on an unspecified date (age at the time of vaccination 73-years-old) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 12Feb2021, the patient experienced arm pain at injection site; and on an unspecified date sore and red. Caller would like to know if she should be worried about the side effects she experienced after the 2nd dose of the Pfizer vaccine. The outcome of the event arm pain at injection site was recovering and other events was unknown.  No follow-up attempts are possible. No further information is expected.
p/vax pt devel SOB & a cough;pt hosp & dx of extensive bilat pneumonia w/bilat infiltrates made;pt intubated for a wk in ICU & tx w/broad spectrum ATB;unspecified cult & bronchoscopy negative;pt recovered;